Find Your Broker
Share Name Share Symbol Market Type Share ISIN Share Description
Tristel Plc LSE:TSTL London Ordinary Share GB00B07RVT99 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  +5.00p +2.13% 240.00p 9,333 08:05:09
Bid Price Offer Price High Price Low Price Open Price
235.00p 245.00p 240.00p 235.00p 235.00p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 22.22 4.01 7.62 31.5 105.0

Tristel (TSTL) Latest News (5)

More Tristel News
Tristel Takeover Rumours

Tristel (TSTL) Share Charts

1 Year Tristel Chart

1 Year Tristel Chart

1 Month Tristel Chart

1 Month Tristel Chart

Intraday Tristel Chart

Intraday Tristel Chart

Tristel (TSTL) Discussions and Chat

Tristel Forums and Chat

Date Time Title Posts
11/12/201807:15The TRISTEL story2,583
14/9/201813:56MRSA cleaner249
15/7/201512:01Tristel PLC: Cleaning up the sector340
03/1/201004:54tristel with charts-
13/2/200607:10TSTL with Charts & News3

Add a New Thread

Tristel (TSTL) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2018-12-11 14:52:25245.00277678.65O
2018-12-11 14:42:47240.002,2205,328.00O
2018-12-11 14:15:23245.004731,158.85O
2018-12-11 12:35:19240.12300720.35O
2018-12-11 12:33:59240.12100240.12O
View all Tristel trades in real-time

Tristel (TSTL) Top Chat Posts

Tristel Daily Update: Tristel Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker TSTL. The last closing price for Tristel was 235p.
Tristel Plc has a 4 week average price of 215p and a 12 week average price of 202.50p.
The 1 year high share price is 342.50p while the 1 year low share price is currently 202.50p.
There are currently 43,730,048 shares in issue and the average daily traded volume is 55,492 shares. The market capitalisation of Tristel Plc is £104,952,115.20.
gopher: Attended the open day in the summer when share price was close to 300p and directors took the opportunity to slot a few At 220p much more reasonably priced for a good quality small cap with opportunity to grow the business. That growth needs to come from abroad as the NHS is a difficult market for all UK suppliers aa there is moral pressure to keep prices low.
sportii: Only a good news from the American front can change the momentum of the share price. Sooner the better!
piedro: To quote the Walbrock report ... "Look to the cash flow statement, and you see share-based payment rose to £665k from £121k. Management rewarded themselves with large bonuses, despite missing earnings forecast. The cancellation of its special dividends took the yield down to 1.6% from approx. 2.5%. To be fair to management, the company share price rose from 30 pence to £2.59, an increase of 760% in the last five years. Surely, management deserves their bonuses for delivering long-term gains to shareholders." - long term investors will remember the pain back in 2010 when the management took the share price from 60p down to 20p - they had to get in outside help to pick the company up again - now again ... "We are working to appoint new Non-Executive Directors to bring fresh ideas and new experiences to our Board" {Annual Report} - the present chairman was only supposed to be 'Interim' - going by past experience, I am thinking that circumstances are obliging him to let go and there may yet be unwelcome revelations to come - I would not be surprised if it was not this same management that is stifling the young talent within the company AIMO, BWDIK GLA and ride the storm.
gopher: I had the impression that the Board members are at a stage in their lives where they want to diversify their wealth having worked hard to make the company successful. Additionally the share price is fairly full at the moment. US looks good but it not going to be instant lift off feeding through to the bottom line quickly, they remain some way from being able to make financial forecasts.
zimbtrader: Approval received! Still a long road ahead before we see revenues from US sales but good news nevertheless. Be interesting to see if this announcement has any effect 9n the share price...
zimbtrader: Thanks Melton. I had missed that detail (that it would be dilutive). I am still, nevertheless, minded to vote against the motion as a matter of principle. It still enables the directors to walk off with money for nothing (effectively) regardless of the price. HAD the motion proposed that the shares vest on any change of control provided the share price is, say, no lower than 10% of the average share price on the day the motion is passed (assuming it is), then I would be more comfortable that they will act in the best interests of ALL shareholders rather than just themselves. It smacks a little too much of greed for my liking...
melton john: "they do not provide the incentive to improve the share price" One-third will vest upon the achievement of a share price of GBP3.50; One-third will vest upon the achievement of a share price of GBP4.25; One-third will vest upon the achievement of a share price of GBP5.00. Why on earth would you be happy if they vested "at or near the current share price" Have I missed something?
cameronm: I hope all shareholders will vote against the proposed 1p options as they do not provide the incentive to improve the share price that is the point of granting options. I would be content if they were exerciseable at or near the current share price.
james188: I very much doubt that the fall in the share price today was down to the article by Richard Beddard referenced above. In essence, it was a well written article which simply questioned whether too much future profit growth was being assumed in the share price as at the end of last week. It is less than 3 weeks ago that I bought a slug of these shares at 268p - and that was by a large distance the most I have ever paid for this share. I expect that the price will continue to bounce around. As I am still adding, I fervently hope so.
piedro: New Share Option Scheme The 2018 Scheme The 2018 Scheme will be put forward for approval by shareholders at the Company's Annual General Meeting. If the 2018 Scheme is approved 990,000 share options will be granted on 1 January 2018 as follows: · Paul Swinney 500,000 options; · Elizabeth Dixon 400,000 options; · Paul Barnes 45,000 options; · David Orr 45,000 options. The options will be exercisable at 1 penny per share and will vest in three equal tranches as follows: · One-third will vest upon the achievement of a share price of £3.50; · One-third will vest upon the achievement of a share price of £4.25; · One-third will vest upon the achievement of a share price of £5.00. To vest, the average share price of Tristel plc must be above the hurdle rate for a minimum three-month period In the event of a change of control of the Company all options will vest. Any vested but unexercised options will expire on 30 June 2021. As an additional condition, the options will only be exercisable if the holder commits to hold the resulting ordinary shares until 30 June 2021 or, if sooner, until a change of control of the Company occurs. - I would prefer @ £4.50, £6.00 and £7.50 - and do not enjoy the talk of change of control - a change of CEO and Chairman, yes AIMHO
Tristel share price data is direct from the London Stock Exchange
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20181212 05:41:44